Di Hu has joined the neurogenomics lab this week! She did her PhD at the University of Oxford as a Clarendon Scholar in the laboratory of Professor Shankar Srinivas. There she investigated how transcription factor ETS2 may act as either an oncogene or tumour suppressor, using a combination of single-cell RNA-sequencing, FACS, high resolution fixed and live imaging, ex vivo pharmacological culture, and in vivo CRISPR genetics.